Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 8/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 7/20 | 0.39 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CX3CR1 | P49238 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.32 |
| ▸ | TYK2 | P29597 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32688114 | 0.95 | CXCR2 (0.41) | RAPGEF4CXCR2ACMSDCHRM5CX3CR1 | |
| SCHEMBL32688388 | 0.76 | KDM4E (0.33) | MEN1KMT2A | |
| SCHEMBL32688253 | 0.76 | CXCR2 (0.36) | CXCR2MEN1KMT2A | |
| SCHEMBL32687991 | 0.74 | — | — | |
| SCHEMBL32688366 | 0.73 | ACMSD (0.47) | CXCR2ACMSDMEN1ALDH1A1CYP1A2 | |
| SCHEMBL32688043 | 0.72 | LMNA (0.45) | CXCR2ACMSDMEN1ALDH1A1KMT2A | |
| SCHEMBL32688407 | 0.72 | ACMSD (0.39) | CXCR2ACMSDMEN1ALDH1A1KMT2A | |
| SCHEMBL32688268 | 0.72 | MEN1 (0.42) | CXCR2ACMSDMEN1ALDH1A1KMT2A | |
| SCHEMBL32688424 | 0.69 | RAPGEF4 (0.44) | RAPGEF4CXCR2ACMSDCHRM5CX3CR1 | |
| SCHEMBL32688486 | 0.69 | RAPGEF4 (0.44) | RAPGEF4CXCR2ACMSDJAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | RAPGEF4 4386/4885CXCR2 2082/4885ACMSD 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.